4//SEC Filing
Jones Jullian G 4
Accession 0000899243-22-008711
CIK 0001826457other
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 6:49 PM ET
Size
5.5 KB
Accession
0000899243-22-008711
Insider Transaction Report
Form 4
Jones Julian G
Chief Business Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-03-01+73,300→ 73,300 totalExercise: $13.41Exp: 2032-02-29→ Common Stock (73,300 underlying)
Footnotes (1)
- [F1]25% of this option shall vest and become exercisable on January 1, 2023, with the remainder vesting in 36 substantially equal monthly installments thereafter.
Documents
Issuer
Monte Rosa Therapeutics, Inc.
CIK 0001826457
Entity typeother
Related Parties
1- filerCIK 0001895356
Filing Metadata
- Form type
- 4
- Filed
- Mar 1, 7:00 PM ET
- Accepted
- Mar 2, 6:49 PM ET
- Size
- 5.5 KB